1. Home
  2. STOK vs SHO Comparison

STOK vs SHO Comparison

Compare STOK & SHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$30.22

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

SHO

Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

HOLD

Current Price

$11.73

Market Cap

1.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
STOK
SHO
Founded
2014
1995
Country
United States
United States
Employees
N/A
37
Industry
Biotechnology: Pharmaceutical Preparations
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
STOK
SHO
Price
$30.22
$11.73
Analyst Decision
Strong Buy
Hold
Analyst Count
10
7
Target Price
$39.20
$9.79
AVG Volume (30 Days)
469.4K
1.9M
Earning Date
05-08-2026
05-05-2026
Dividend Yield
N/A
3.66%
EPS Growth
92.73
N/A
EPS
N/A
N/A
Revenue
$184,420,000.00
N/A
Revenue This Year
N/A
$3.95
Revenue Next Year
$77.49
$2.30
P/E Ratio
N/A
$966.33
Revenue Growth
404.50
N/A
52 Week Low
$11.17
$8.52
52 Week High
$40.22
$11.90

Technical Indicators

Market Signals
Indicator
STOK
SHO
Relative Strength Index (RSI) 47.17 71.17
Support Level $28.27 $8.81
Resistance Level $35.11 N/A
Average True Range (ATR) 1.43 0.24
MACD 0.13 0.01
Stochastic Oscillator 46.73 77.82

Price Performance

Historical Comparison
STOK
SHO

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in California which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its Hotel Ownership Segment.

Share on Social Networks: